|
1
|
van Berlo JH, Maillet M and Molkentin JD:
Signaling effectors underlying pathologic growth and remodeling of
the heart. J Clin Invest. 123:37–45. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen C, Li R, Ross RS and Manso AM:
Integrins and integrin-related proteins in cardiac fibrosis. J Mol
Cell Cardiol. 93:162–174. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Koshman YE, Patel N, Chu M, Iyengar R, Kim
T, Ersahin C, Lewis W, Heroux A and Samarel AM: Regulation of
connective tissue growth factor gene expression and fibrosis in
human heart failure. J Card Fail. 19:283–294. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Creemers EE and van Rooij E: Function and
therapeutic potential of non-coding RNAs in cardiac fibrosis. Circ
Res. 118:108–118. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li M, Wang N, Zhang J, He HP, Gong HQ,
Zhang R, Song TF, Zhang LN, Guo ZX, Cao DS, et al: MicroRNA-29a-3p
attenuates ET-1-induced hypertrophic responses in H9c2
cardiomyocytes. Gene. 585:44–50. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang Y, Wang R, Du W, Wang S, Yang L, Pan
Z, Li X, Xiong X, He H, Shi Y, et al: Downregulation of miR-151-5p
contributes to increased susceptibility to arrhythmogenesis during
myocardial infarction with estrogen deprivation. PLoS One.
8:e729852013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen LW, Zhu LL, Ji Q, Zhu H, Ren YZ, Fan
ZG, Li XB, Gao XF, Zhang YJ and Tian NL: Relationship between
myocardial microRNA-30a expression and myocardial fibrosis in rats
post myocardial infarction. Zhonghua Xin Xue Guan Bing Za Zhi.
44:443–449. 2016.(In Chinese). PubMed/NCBI
|
|
8
|
Yuan CT, Li XX, Cheng QJ, Wang YH, Wang JH
and Liu CL: MiR-30a regulates the atrial fibrillation-induced
myocardial fibrosis by targeting snail 1. Int J Clin Exp Pathol.
8:15527–15536. 2015.PubMed/NCBI
|
|
9
|
Forini F, Kusmic C, Nicolini G, Mariani L,
Zucchi R, Matteucci M, Iervasi G and Pitto L: Triiodothyronine
prevents cardiac ischemia/reperfusion mitochondrial impairment and
cell loss by regulating miR30a/p53 axis. Endocrinology.
155:4581–4590. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gutiérrez-Escolano A, Santacruz-Vázquez E
and Gómez-Pérez F: Dysregulated microRNAs involved in
contrast-induced acute kidney injury in rat and human. Ren Fail.
37:1498–1506. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yin X, Peng C, Ning W, Li C, Ren Z, Zhang
J, Gao H and Zhao K: miR-30a downregulation aggravates pressure
overload-induced cardiomyocyte hypertrophy. Mol Cell Biochem.
379:1–6. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gao X, Ma YT, Yang YN, Xiang Y, Chen BD,
Liu F and Du L: Recombinant adeno-associated virus serotype 9
transfection of rats H9C2 cells in vitro. Xi Bao Yu Fen Zi Mian Yi
Xue Za Zhi. 26:18–20. 2010.(In Chinese). PubMed/NCBI
|
|
13
|
Bish LT, Morine K, Sleeper MM, Sanmiguel
J, Wu D, Gao G, Wilson JM and Sweeney HL: Adeno-associated virus
(AAV) serotype 9 provides global cardiac gene transfer superior to
AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. Hum Gene Ther.
19:1359–1368. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kalisz M, Baranowska B, Wolinska-Witort E,
Maczewski M, Mackiewicz U, Tulacz D, Gora M, Martynska L and Bik W:
Total and high molecular weight adiponectin levels in the rat model
of post-myocardial infarction heart failure. J Physiol Pharmacol.
66:673–680. 2015.PubMed/NCBI
|
|
15
|
Bagno LL, Carvalho D, Mesquita F, Louzada
RA, Andrade B, Kasai-Brunswick TH, Lago VM, Suhet G, Cipitelli D,
Werneck-de-Castro JP, et al: Sustained IGF-1 secretion by
adipose-derived stem cells improves infarcted heart function. Cell
Transplant. 25:1609–1622. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen J, Huang C, Zhang B, Huang Q, Chen J
and Xu L: The effects of carvedilol on cardiac structural
remodeling: The role of endogenous nitric oxide in the activity of
carvedilol. Mol Med Rep. 7:1155–1158. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abdel-Hamid AAM and Firgany A-D:
Atorvastatin alleviates experimental diabetic cardiomyopathy by
suppressing apoptosis and oxidative stress. J Mol Histol.
46:337–345. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Parimala M, Debjani M, Vasanthi HR and
Shoba FG: Nymphaea nouchali Burm. f. hydroalcoholic seed
extract increases glucose consumption in 3T3-L1 adipocytes through
activation of peroxisome proliferator-activated receptor gamma and
insulin sensitization. J Adv Pharm Technol Res. 6:183–189. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wojcik B, Harasim E, Zabielski P,
Chabowski A and Gorski J: Effect of tachycardia on lipid metabolism
and expression of fatty acid transporters in heart ventricles of
the rat. J Physiol Pharmacol. 66:691–699. 2015.PubMed/NCBI
|
|
20
|
Pan W, Zhong Y, Cheng C, Liu B, Wang L, Li
A, Xiong L and Liu S: MiR-30-regulated autophagy mediates
angiotensin II-induced myocardial hypertrophy. PLoS One.
8:e539502013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xia X: The relationship of serum miR-30a
and heart failure in children with congenital heart disease. J Clin
Pediatr. 32:607–609. 2014.http://www.jcp-sh.org.cn/EN/abstract/abstract8665.shtml
|
|
22
|
Leask A and Abraham DJ: All in the CCN
family: Essential matricellular signaling modulators emerge from
the bunker. J Cell Sci. 119:4803–4810. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shimo T, Nakanishi T, Nishida T, Asano M,
Kanyama M, Kuboki T, Tamatani T, Tezuka K, Takemura M, Matsumura T,
et al: Connective tissue growth factor induces the proliferation,
migration, and tube formation of vascular endothelial cells in
vitro, and angiogenesis in vivo. J Biochem. 126:137–145. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang B, Haldar SM, Lu Y, Ibrahim OA, Fisch
S, Gray S, Leask A and Jain MK: The Kruppel-like factor KLF15
inhibits connective tissue growth factor (CTGF) expression in
cardiac fibroblasts. J Mol Cell Cardiol. 45:193–197. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hayata N, Fujio Y, Yamamoto Y, Iwakura T,
Obana M, Takai M, Mohri T, Nonen S, Maeda M and Azuma J: Connective
tissue growth factor induces cardiac hypertrophy through Akt
signaling. Biochem Biophys Res Commun. 370:274–278. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bonniaud P, Martin G, Margetts PJ, Ask K,
Robertson J, Gauldie J and Kolb M: Connective tissue growth factor
is crucial to inducing a profibrotic environment in
‘fibrosis-resistant’ BALB/c mouse lungs. Am J Respir Cell Mol Biol.
31:510–516. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang J, Duan L, Guo T, Gao Y, Tian L, Liu
J, Wang S and Yang J: Downregulation of miR-30c promotes renal
fibrosis by target CTGF in diabetic nephropathy. J Diabetes
Complications. 30:406–414. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Su Z, Wei G, Wei L, Liu J and Li X:
Effects of rhBNP on myocardial fibrosis after myocardial infarction
in rats. Int J Clin Exp Pathol. 8:6407–6415. 2015.PubMed/NCBI
|
|
29
|
Duisters RF, Tijsen AJ, Schroen B,
Leenders JJ, Lentink V, van der Made I, Herias V, van Leeuwen RE,
Schellings MW, Barenbrug P, et al: miR-133 and miR-30 regulate
connective tissue growth factor: Implications for a role of
microRNAs in myocardial matrix remodeling. Circ Res. 104:170–178.
2009. View Article : Google Scholar : PubMed/NCBI
|
